Vimarsana
Biggest News Aggregation in the World

Vida Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vida Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vida Ventures Today - Breaking & Trending Today

Alterome Therapeutics Raises $132M in Series B Financing - Vimarsana News

Alterome Therapeutics Raises $132M in Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Alterome Therapeutics Raises $132 Million in Series B Financing Led by Goldman Sachs Alternatives - Vimarsana News

Alterome Therapeutics Raises $132 Million in Series B Financing Led by Goldman Sachs Alternatives

Proceeds support advancement of two next-generation precision oncology programs into clinical development within 12 monthsFinancing led by Goldman Sachs Alternatives with participation by Canaan Partners, Driehaus Capital Management, Invus, Digitalis Ventures, Blue Owl Capital, and existing investorsSAN DI...

Alterome Therapeutics secures $132m in Series B funding - Vimarsana News

Alterome Therapeutics secures $132m in Series B funding

Alterome Therapeutics, a biopharmaceutical company, has closed a $132m Series B financing round.

Upsized Kyverna IPO Gets $319M to Bring CAR T-Therapy to Autoimmune Diseases - Vimarsana News

Upsized Kyverna IPO Gets $319M to Bring CAR T-Therapy to Autoimmune Diseases

Cell therapies were first validated in cancer, but Kyverna Therapeutics aims to show they’re safe enough for autoimmune diseases. The biotech plans to deploy its IPO cash across clinical trials in lupus nephritis, multiple sclerosis, systemic sclerosis, and myasthenia gravis.

Biotech Kyverna surges 36 percent in US debut - Vimarsana News

Biotech Kyverna surges 36 percent in US debut

Bringing Taiwan to the World and the World to Taiwan